Is vaccination with quadrivalent HPV vaccine after loop electrosurgical excision procedure effective in preventing recurrence in patients with high-grade cervical intraepithelial neoplasia (CIN2-3)?

Gynecologic Oncology

Volumn 130, Issue 2, 2013, Pages 264-268

  Kang, Woo Dae ^a   Choi, Ho Sun ^a   Kim, Seok Mo ^a  

^a Chonnam National University Medical School   (South Korea)

Author keywords

High grade CIN HPV LEEP Vaccine

Indexed keywords

WART VIRUS VACCINE;

ADULT; ARTICLE; CANCER PREVENTION; CANCER RECURRENCE; CANCER SURGERY; ELECTROSURGERY; FEMALE; FOLLOW UP; HUMAN; LOOP ELECTROSURGICAL EXCISION PROCEDURE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RECURRENCE RISK; RETROSPECTIVE STUDY; RISK FACTOR; UTERINE CERVIX CARCINOMA IN SITU; VACCINATION;

HIGH GRADE CIN; HPV; LEEP; VACCINE;

ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; ELECTROSURGERY; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; PAPILLOMAVIRUS VACCINES; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; UTERINE CERVICAL NEOPLASMS; VACCINATION;

EID: 84880303715     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2013.04.050     Document Type: Article

References (19)

1. A.V. Pinto, and C.P. Crum Natural history of cervical neoplasia: defining progression and its consequences Clin Obstet Gynecol 43 2000 352 362
2. N.F. Schlecht, S. Kulaga, and J. Robitaille Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia JAMA 286 2001 3106 3114
3. E. Kucera, G. Sliutz, K. Czerwenka, G. Breitenecker, S. Leodolter, and A. Reinthaller Is high-risk human papillomavirus infection associated with cervical intraepithelial neoplasia eliminated after conization by large-loop excision of the transformation zone? Eur J Obstet Gynecol Reprod Biol 100 2001 72 76
4. Y. Nagai, T. Maehama, T. Asato, and K. Kanazawa Persistence of human papillomavirus infection after therapeutic conization for CIN 3: is it an alarm for disease recurrence? Gynecol Oncol 79 2000 294 299
5. M.F. Mitchell, G. Tortolero-Luna, E. Cook, L. Whittaker, H. Rhodes-Morris, and E. Silva A randomized clinical trial of cryotherapy, laser vaporization and loop electrosurgical excision for treatment of squamous intra-epithelial lesions of the cervix Obstet Gynecol 92 1998 737 744
6. P. Holowaty, A.B. Miller, T. Rohan, and T. To Natural history of dysplasia of the uterine cervix J Natl Cancer Inst 91 1999 252 258
7. J. Nuovo, J. Melnikow, A.R. Willan, and B.K. Chan Treatment outcomes for squamous intraepithelial lesions Int J Gynaecol Obstet 68 2000 25 33
8. The FUTURE II Study Group Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions N Engl J Med 356 2007 1915 1927
9. The FUTURE II Study Group Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3 and adenocarcinoma in situ: a combined analysis of four randomised clinical trials Lancet 369 2007 1861 1868
10. J. Paavonen, P. Naud, J. Salmeron, C.M. Wheeler, S.N. Chow, and D. Apter Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women Lancet 374 2009 301 314
11. N. Munoz, R. Manalastas, P. Pitisuttihum, D. Tresukosol, J. Monsonego, and K. Ault Safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women between 24 and 45 years of age: a randomized, double-blind trial Lancet 373 2009 1949 1957
12. E.A. Joura, S.M. Garland, J. Paavonen, D.G. Ferris, G. Perez, and K.A. Ault Effect of the human papillomavirus (HPV) quadrivalent vaccine in a subgroup of women with cervical and vulvar disease: retrospective pooled analysis of trial data BMJ 344 2012 e1401
13. K. Elfgren, M. Jacobs, J.M. Walboomers, C.J. Meijer, and J. Dillner Rate of human papillomavirus clearance after treatment of cervical intraepithelial neoplasia Obstet Gynecol 100 2002 965 971
14. L. Kjellberg, G. Wadell, F. Bergman, M. Isaksson, T. Angstrom, and J. Dillner Regular disappearance of the human papillomavirus genome after conization of cervical dysplasia by carbon dioxide laser Am J Obstet Gynecol 183 2000 1238 1242
15. S.H. Song, J.K. Lee, M.J. Oh, J.Y. Hur, J.Y. Na, and Y.K. Park Persistent HPV infection after conization in patients with negative margins Gynecol Oncol 101 2006 418 422
16. Y.T. Kim, J.M. Lee, S.Y. Hur, C.H. Cho, Y.T. Kim, and S.C. Kim Clearance of human papillomavirus infection after successful conization in patients with cervical intraepithelial neoplasia Int J Cancer 126 8 2010 1903 1909
17. W.D. Kang, M.J. Oh, S.M. Kim, J.H. Nam, C.S. Park, and H.S. Choi Significance of human papillomavirus genotyping with high-grade cervical intraepithelial neoplasia treated by a loop electrosurgical excision procedure Am J Obstet Gynecol 203 1 Jul 2010 72.e1 72.e6
18. X. Castellsague, N. Munoz, P. Pitisuttithum, D. Ferris, J. Monsonego, and K. Ault End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24-45 years of age Br J Cancer 105 2011 28 37
19. Y.D. Choi, W.W. Jung, J.H. Nam, H.S. Choi, and C.S. Park Detection of HPV genotypes in cervical lesions by the HPV DNA Chip and sequencing Gynecol Oncol 98 2005 369 375